deferoxamine has been researched along with Intestinal Diseases in 4 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Intestinal Diseases: Pathological processes in any segment of the INTESTINE from DUODENUM to RECTUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two maintenance hemodialysis patients receiving deferoxamine to chelate iron and aluminum developed intestinal mucormycosis." | 7.67 | Intestinal mucormycosis in hemodialysis patients following deferoxamine. ( Eiser, AR; Neff, MS; Slifkin, RF, 1987) |
| "A case of fatal intestinal mucormycosis in a 57-year-old female hemodialysis patient who had received desferrioxamine (DFO) for aluminum overload is reported." | 4.78 | Intestinal mucormycosis in a hemodialysis patient treated with desferrioxamine. ( Abe, F; Hotchi, M; Ito, M; Kaneko, T; Okada, Y; Yamada, K, 1991) |
| "Two maintenance hemodialysis patients receiving deferoxamine to chelate iron and aluminum developed intestinal mucormycosis." | 3.67 | Intestinal mucormycosis in hemodialysis patients following deferoxamine. ( Eiser, AR; Neff, MS; Slifkin, RF, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roberts, RJ | 1 |
| Nayfield, S | 1 |
| Soper, R | 1 |
| Kent, TH | 1 |
| Kaneko, T | 1 |
| Abe, F | 1 |
| Ito, M | 1 |
| Hotchi, M | 1 |
| Yamada, K | 1 |
| Okada, Y | 1 |
| Finkelstein, I | 1 |
| Toledo-Pereyra, LH | 1 |
| Castillo, M | 1 |
| Castellanos, J | 1 |
| Eiser, AR | 1 |
| Slifkin, RF | 1 |
| Neff, MS | 1 |
1 review available for deferoxamine and Intestinal Diseases
| Article | Year |
|---|---|
Intestinal mucormycosis in a hemodialysis patient treated with desferrioxamine.
Topics: Aluminum; Deferoxamine; Female; Humans; Intestinal Diseases; Middle Aged; Mucormycosis; Renal Dialys | 1991 |
3 other studies available for deferoxamine and Intestinal Diseases
| Article | Year |
|---|---|
Acute iron intoxication with intestinal infarction managed in part by small bowel resection.
Topics: Deferoxamine; Humans; Ileostomy; Infant; Infarction; Intestinal Diseases; Intestine, Small; Iron; Ma | 1975 |
Comparative analysis of pharmacological agents following small bowel ischemia.
Topics: Acute Disease; Allopurinol; Animals; Deferoxamine; Drug Combinations; Free Radicals; Intestinal Dise | 1988 |
Intestinal mucormycosis in hemodialysis patients following deferoxamine.
Topics: Deferoxamine; Humans; Intestinal Diseases; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; R | 1987 |